Bharat Immunologicals and Biologicals Corporation Q1FY22 net profit at Rs. 1.92 Cr

Bharat Immunologicals and Biologicals Corporation Q1FY22 net profit at Rs. 1.92 Cr

By: ICN Bureau

Last updated : January 27, 2022 5:49 pm



The company reported total income Rs.18.57 crores during the period ended June 30, 2020.


Bharat Immunologicals and Biologicals Corporation Ltd has reported total income of Rs.14.46 crores during the period ended June 30, 2021 as compared to Rs.24.69 crores during the period ended March 31, 2021.

The company reported total income Rs.18.57 crores during the period ended June 30, 2020.

The company has posted net profit of Rs.1.92 crores for the period ended June 30, 2021 as against loss of Rs.(6.53) crores for the period ended March 31, 2021. It posted net loss of Rs.(0.7845) crores for the period ended June 30, 2020.

Bharat Immunologicals and Biologicals Corporation Ltd

First Published : July 28, 2021 12:00 am